ZFP69 is a zinc finger domain transcription factor that regulates lipid metabolism and glucose homeostasis, with significant implications for type 2 diabetes pathogenesis. As a DNA-binding transcription factor, ZFP69 controls triglyceride storage and redistribution in adipose tissue and liver 1. The gene was identified through positional cloning in polygenic mouse models of obesity-associated diabetes, where functional variants alter disease susceptibility 2. Loss-of-function mutations caused by retrotransposon insertion in C57BL/6J and NZO mice reduce diabetes prevalence, while functional alleles promote hyperglycemia, reduced gonadal fat mass, and increased hepatic triglycerides 3. ZFP69 overexpression in transgenic mice induces hepatic insulin resistance and hyperlipidemia by downregulating genes involved in glucose and lipid metabolism, including Nampt, Lpin2, Gys2, and Ppargc1α 4. The human ortholog ZNF642 shows elevated expression in adipose tissue from type 2 diabetic patients compared to controls 2, suggesting ZFP69 dysfunction contributes to human metabolic disease. However, ZFP69 alone is insufficient to cause overt diabetes, indicating its diabetogenic effects require genetic synergy with other loci 4.